EURACTIV PR

An easy way of publishing your relevant EU press releases.

New clinical trial rules to benefit patients, not industry

Date

03 Apr 2014

Sections

Health & Consumers

Commenting on new rules for clinical trials on medicinal products for human use in the European Parliament this afternoon, GUE/NGL MEP Alda Sousa welcomed the good results achieved by Parliament's rapporteurs and shadow rapporteurs and said they deserved a positive vote.

However, she told Commissioner Borg, who was present in the Chamber, that if patients in Europe are better protected because of these new rules, it is largely due to improvements made by the European Parliament "as the original Commission proposal looked as if it had been written by the pharmaceutical industry".

She added: "We succeeded in our efforts to improve the proposal to guarantee patients' rights, to guarantee transparency and to ensure the safety and rights of all those who are going to be involved in clinical trials. It is not from a perspective of competitiveness that we should deal with this but from a perspective of competence."

GUE/NGL Press Contacts:

Gay Kavanagh +32 473 84 23 20

European United Left / Nordic Green Left

European Parliamentary Group

www.guengl.eu

 

Jobs

StP Communications
Project Manager Communication
Max Planck Institute for Legal History and Legal Theory
Three PhD Students (m/f/div)
European Partnership for Democracy
Communications Officer
Friends of the Earth Europe
Corporate Accountability Campaigner
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH
Programme Component Manager (m/f/d) for ComSSA PCU
EuRIC aisbl
Technical Advisor
EBF - European Banking Federation
HR Officer
Cambridge Econometrics
Graduate Economist